SavedAdd your journal

Journals / Tıp Araştırmaları Dergisi / 2015 / Cilt: 13 - Sayı: 1

Achalasia

Akalazya

Burak SUVAK
Özlem SUVAK
Ahmet Cumhur DÜLGER
Pages
44–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Recently a new technique has been described as called peroral endoscopic myotomy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Achalasia is a primary esophageal motor disorder.
📊
Key Findings & Data:Besides being cause of symptoms such as dysphagia, chest pain, regurgitation and weight loss it is precancerous.
💡
Conclusion & Impact:Recently a new technique has been described as called peroral endoscopic myotomy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Achalasia is a primary esophageal motor disorder. Besides being cause of symptoms such as dysphagia, chest pain, regurgitation and weight loss it is precancerous. Due to its etiology is still unknown all treatment options are palliative with the intention to weaken the lower esophageal sphincter. There are medical, endoscopic, surgery treatment options. Recently a new technique has been described as called peroral endoscopic myotomy.

Özet

Akalazya primer özofagus motor hastalığıdır. Disfaji, göğüs ağrısı, regürjitasyon ve kilo kaybına nedenolmasının yanında prekanserözdür. Etyolojisi hala bilinmediğinden tüm tedavi seçenekleri alt özofagussfinkterinin zayıflatılmasına yönelik palyatiftir. Medikal, endoskopik, cerrahi tedavi seçenekleri vardır. Yakınzamanda peroral endoskopik myotomi diye adlandırılan yeni bir teknik tanımlanmıştır.

🔖

Cite This Article

SUVAK, B., SUVAK, Ö., DÜLGER, A. C. (2015). Achalasia. Tıp Araştırmaları Dergisi, Cilt: 13 - Sayı: 1, 44–49. https://ajindex.com/articles/361626

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Boeckxstaens GE. The lower oesophageal sphincter. Neurogastroenterol Motil 2005; 17 (suppl 1): 13–21
  2. Kahrilas PJ, Kishk SM, Helm JF, Dodds WJ, Harig JM, Hogan WJ. Comparison of pseudoachalasia and achalasia. Am J Med 1987; 82: 439–46
  3. Tracey JP, Traube M. Diffi culties in the diagnosis of pseudoachalasia. Am J Gastroenterol 1994; 89: 2014–18. 4. de Borst JM, Wagtmans MJ, Fockens P, et al. Pseudoachalasia caused by pancreatic carcinoma. Eur J Gastroenterol Hepatol 2003; 15: 825–28
  4. Farrukh A, DeCaestecker J, Mayberry JF. An epidemiological study of achalasia among the south Asian population of Leicester, 1986–2005. Dysphagia 2008; 23: 161–64
  5. Sadowski DC, Ackah F, Jiang B, et al. Achalasia: incidence, prevalence and survival. A populationbased study. Neurogastroenterol Motil 2010; 22: e256–61
  6. Birgisson S, Richter JE. Achalasia in Iceland, 1952–2002: an epidemiologic study. Dig Dis Sci 2007; 52: 1855–60
  7. Gennaro N, Portale G, Gallo C, et al. Esophageal achalasia in the Veneto region: epidemiology and treatment. Epidemiology and treatment of achalasia. J Gastrointest Surg 2011; 15: 423–28
  8. Enestvedt BK, Williams JL, Sonnenberg A. Epidemiology and practice patterns of achalasia in a large multi-centre database. Aliment Pharmacol Ther 2011; 33: 1209–14
  9. Booy JD, Takata J, Tomlinson G, et al. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis Esophagus 2012; 25: 209–13
  10. Clark SB, Rice TW, Tubbs RR, et al. The nature of the myenteric infi ltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000; 24: 1153–58
  11. Storch WB, Eckardt VF, Wienbeck M, et al. Autoantibodies to Auerbach’s plexus in achalasia. Cell Mol Biol (Noisy-le-grand) 1995;41: 1033–38
  12. Moses PL, Ellis LM, Anees MR, et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal refl ux disease. Gut 2003; 52: 629–36
  13. Castagliuolo I, Brun P, Costantini M, et al. Esophageal achalasia: is the herpes simplex virus really innocent? J Gastrointest Surg 2004; 8: 24– 30
  14. Facco M, Brun P, Baesso I, et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 2008; 103: 1598– 609
  15. De la Concha EG, Fernandez-Arquero M, Mendoza JL, et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens 1998; 52: 381–84
  16. Paladini F, Cocco E, Cascino I, et al. Agedependent association of idiopathic achalas